Health disparities in diagnosis and treatment of hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 2046-2484|4|6|143-145

ISSN： 2046-2484

Source： CLINICAL LIVER DISEASE (ELECTRONIC), Vol.4, Iss.6, 2014-12, pp. : 143-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

By  

MEDICINAL RESEARCH REVIEWS, Vol. 38, Iss. 2, 2018-03 ,pp. : 741-767

John Wiley & Sons Inc

Access to resources Recommend Favorite

Criteria for liver transplantation in hepatocellular carcinoma

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 4, 2015-10 ,pp. : 100-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intra‐arterial locoregional therapy in the management of hepatocellular carcinoma

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 11, Iss. 1, 2018-01 ,pp. : 6-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma

By  

SMALL, Vol. 14, Iss. 5, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized management of hepatocellular carcinoma based on molecular information: Future prospects

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 6, 2015-06 ,pp. : 132-135

John Wiley & Sons Inc

Access to resources Recommend Favorite